Anna N Wilkinson, James G Mainprize, Martin J Yaffe, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2452821
Objective: To determine the cost-effectiveness of population-based breast cancer screening in the context of current treatment standards. Incremental cost-effectiveness ratios for deaths averted, life-years (LYs) gained, and incre...
Read More
Syed Mahfuz Al Hasan, Debbie L Bennett, and Adetunji T Toriola. Bull World Health Organ.2025 Aug 1;103(8):470-483
We collected data on breast cancer screening programmes and breast cancer mortality from the World Health Organization's Global Health Observatory, the Global Burden of Diseases 2021 study and the Eurostat database. Between 2015 a...
Read More
Sida Huang, Sarah J Westvold, Pamela R Soulos, et al. JAMA Netw Open. 2025 Apr 1;8(4):e255322
Screening mammography promotes early detection of breast cancer and is associated with reduced breast cancer mortality. Screening history prior to diagnosis may impact stage at diagnosis and breast cancer mortality. Among 13,028 i...
Read More
Javier David Benitez Fuentes, Eileen Morgan, Alicia de Luna Aguilar et al. JAMA Oncol. 2024 Jan 1;10(1):71-78
Objective: To assess the global distribution of breast cancer stage by country, age group, calendar period, and socioeconomic status using population-based data. Data were available for 2.4 million women with breast cancer from 81...
Read More
Yuanyan Tang, Jia Zhu and Zhengren Liu. Cancer Invest. 2025 Sep;43(8):610-622
This study analyzed the trends of BC among Chinese women from 1997 to 2021 to support evidence-based for the prevention, screening and treatment strategies of female BC in China. We extracted data on BC incidence, mortality, preva...
Read More
Shuai Xu, Sara Murtagh, Yunan Han,et al. JAMA Netw Open. 2024 Jan 2;7(1):e2353331
Breast cancer in young women has a less favorable prognosis compared with older women. This cross-sectional study used data from Surveillance, Epidemiology, and End Results 17 registries (2000-2019). Women aged 20 to 49 years with...
Read More
Dechuang Jiao, Jiujun Zhu, Dandan Wang, et al. Breast. 2026 Mar 23:87:104777
Accurate estimates of the global burden of young breast cancer (YBC) are lacking. In 2021, YBC accounted for substantial global disease burden, with 81,856 new cases, 687,819 prevalent cases, 18,597 deaths, and 1,178,721 DALYs. Fr...
Read More
Yibei Li, Danqi Huang, Jingyi Liu, et al. J Natl Cancer Cent. 2026 Feb 11;6(2):149-158
Early-onset cancer is a significant public health threat in females, yet comprehensive data on its global burden and temporal trends remain limited. This study analyzed the incidence, mortality, and disability-adjusted life years...
Read More
Silvia Mignozzi, Claudia Santucci, Gianfranco Alicandro, et al. Cancer Causes Control. 2026 Apr 3;37(5):79
An increasing cancer incidence has been observed among recent generations over the last decade. However, apart from colorectal cancer, these increases were not associated with rises in mortality. We extracted death counts for indi...
Read More
Yingying Li, Wenfu Song, Ping Gao, et al. BMC Cancer. 2025 Feb 24;25(1):330
Female breast cancer, cervical cancer, uterine cancer, and ovarian cancer (FBCUO) pose a significant threat to global public health. Incidence, age-standardized incidence rate (ASIR), deaths, age-standardized mortality rate (ASMR)...
Read More
Breast cancer and reproductive system cancers remain significant public health threats for Chinese women. The year‐ and age‐specific estimates of the incidence, mortality, and disability‐adjusted life‐years (DALYs) associated with...
Read More
GBD 2023 Breast Cancer Collaborators. Lancet Oncol. 2026 Mar;27(3):302-326
Breast cancer is a leading cause of mortality and morbidity among females worldwide. In 2023, there were an estimated 2.30 million breast cancer incident cases, 764 000 deaths, and 24.1 million DALYs among females globally. In the...
Read More